Entities / Company
AxoGen.
company
- Reports this week
- 0
- Active events
- 0
- Connections
- 26
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
-
AxoGen stock is currently traded on the Nasdaq exchange.Some support1 report
-
AxoGen and Harris researched tissue regeneration with colleagues on August 11, 2026.Some support1 report
-
Michael Dale was named CEO of AxoGen, a company with operations in Tampa, Florida.Some support5 reports
-
AxoGen provided a strategic investment to Trace Biosciences on July 29, 2026.Some support1 report
Gone quiet
No new reports in 90+ days-
AxoGen is seeking BLA approval for its Avance Nerve Graft, and the FDA extended the review date for the application.Some support5 reports1 development inside
-
AxoGen, a Florida-based company, announced on July 3rd that it invested in Avance and presented at a Goldman Sachs conference.Speculative1 report
-
Zacks Earnings ESP provided insight into business conditions for AxoGen on July 29, 2025.Some support1 report
-
AxoGen operates within the medical instruments industry, and Zacks Rank harnesses earnings estimate revisions for stock analysis.Some support1 report
-
Automated Insights generated a story on August 5, 2025, involving the company AxoGen.Some support1 report
-
First Light Asset Management is reported as the largest shareholder of AxoGen.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around AxoGen this week
News at the entities that move AxoGen most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves AxoGen
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves AxoGen
-
Harris OperationalHarris was appointed to the Board of Regents and serves as President of the University of Washington.Moves AxoGen
-
Tampa Shared contextCoastal development in the Tampa Bay/Southwest Florida region has negatively impacted the local ecosystem.Moves AxoGen
Connections
The 6 strongest of 26, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA formally regulates AxoGen's product development, managing the BLA filing and clearance process for its medical devices.
-
Michael Dale Structural
Michael Dale holds the role of CEO and Director of AxoGen.
-
Nasdaq Structural
AxoGen is a company that trades on the Nasdaq stock exchange.
-
Tampa Shared context
AxoGen operates and is based within the geographical context of Tampa, Florida.
-
Harris Operational
The relationship is implied to be a collaborative research partnership focused on tissue regeneration.
-
Alachua Shared context
AxoGen operates from an office located in Alachua, Florida.
History
Events by the month they beganAugust 2026
2 eventsJune 2026
8 events- The FDA has issued a Major Amendment regarding AxoGen's submission on August 25, 2025.
- Michael Dale was named CEO of AxoGen, a company with operations in Tampa, Florida.
- AxoGen is seeking BLA approval for its Avance Nerve Graft, and the FDA extended the review date for the application.
- AxoGen, a Florida-based company, announced on July 3rd that it invested in Avance and presented at a Goldman Sachs conference.
- Zacks Earnings ESP provided insight into business conditions for AxoGen on July 29, 2025.
- AxoGen operates within the medical instruments industry, and Zacks Rank harnesses earnings estimate revisions for stock analysis.
- Automated Insights generated a story on August 5, 2025, involving the company AxoGen.
- First Light Asset Management is reported as the largest shareholder of AxoGen.